Clinical Trial Update: Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating rituximab for membranoproliferative glomerulonephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranoproliferative Glomerulonephritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Glomerulonephritis, Membranoproliferative | Phase 1 | Status: COMPLETED